Johnson & Johnson reveals its Covid vaccine is 66% effective in clinical trial
Johnson and Johnson’s coronavirus vaccine is 66 per cent effective against the disease, early trial results reveal. And it was shown to prevent severe cases of the virus in 86 per cent of cases – with no participants who were vaccinated needing hospital treatment or dying 28 days after the dose was administered. The jab … Read more